Heparin administration in coronary angiography
Phase 2
- Conditions
- Atherosclerotic heart disease.Atherosclerotic heart disease
- Registration Number
- IRCT201202199080N1
- Lead Sponsor
- Hamadan university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
all patients with CAD referred to Ekbatan hospital for coronary angiography.
Exclusion criteria: patients with severe AS, PVD, coagulopathy and angiography procedures more than 30 minutes.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematoma, active bleeding. Timepoint: until 30 days after angiography. Method of measurement: inspection and clinical evaluation.
- Secondary Outcome Measures
Name Time Method Cerebrovascualr accident. Timepoint: until 30 days after angiography. Method of measurement: inspection and clinical evaluation.